tiprankstipranks
Trending News
More News >
DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
US Market

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Compare
516 Followers
See the Price Targets and Ratings of:

XRAY Analyst Ratings

Hold
13Ratings
Hold
3 Buy
10 Hold
0 Sell
Based on 13 analysts giving stock ratings to
DENTSPLY
SIRONA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XRAY Stock 12 Month Forecast

Average Price Target

$17.41
▲(6.55%Upside)
Based on 13 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $17.41 with a high forecast of $25.00 and a low forecast of $14.00. The average price target represents a 6.55% change from the last price of $16.34.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","21":"$21","30":"$30","16.5":"$16.5","25.5":"$25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$17.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.5,21,25.5,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.93,14.781538461538462,15.633076923076922,16.484615384615385,17.336153846153845,18.18769230769231,19.03923076923077,19.89076923076923,20.74230769230769,21.593846153846155,22.445384615384615,23.29692307692308,24.14846153846154,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.93,14.197692307692307,14.465384615384615,14.733076923076922,15.000769230769231,15.268461538461539,15.536153846153846,15.803846153846154,16.071538461538463,16.33923076923077,16.606923076923078,16.874615384615385,17.142307692307693,{"y":17.41,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.93,13.935384615384615,13.94076923076923,13.946153846153846,13.951538461538462,13.956923076923077,13.962307692307693,13.967692307692307,13.973076923076922,13.978461538461538,13.983846153846153,13.989230769230769,13.994615384615384,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.26,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.15,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.03,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.08,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.67,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.64,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.06,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.45,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.78,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.56,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.65,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.93,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.00Average Price Target$17.41Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on XRAY
TipRanks AITipRanks
Not Ranked
TipRanks
$16
Hold
-2.08%
Downside
Reiterated
05/23/25
DENTSPLY SIRONA faces significant financial challenges, as evidenced by declining revenues and profitability, which heavily impact its overall score. Technical analysis provides some short-term optimism, but long-term resistance remains. Valuation is unattractive due to a negative P/E ratio, though the dividend yield is a partial offset. The earnings call highlights operational efficiency improvements, yet U.S. sales declines and tariff impacts are concerns. Corporate events indicate potential instability in leadership.
Barrington Analyst forecast on XRAY
Michael PetuskyBarrington
Barrington
$20$21
Buy
28.52%
Upside
Reiterated
05/12/25
Dentsply Sirona price target raised to $21 from $20 at BarringtonDentsply Sirona price target raised to $21 from $20 at Barrington
UBS
$27$25
Buy
53.00%
Upside
Reiterated
05/09/25
Dentsply Sirona price target lowered to $25 from $27 at UBSDentsply Sirona price target lowered to $25 from $27 at UBS
Mizuho Securities Analyst forecast on XRAY
Steven ValiquetteMizuho Securities
Mizuho Securities
$16$17
Hold
4.04%
Upside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Raised to $17 at MizuhoMizuho analyst Steven Valiquette raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $16.00) while maintaining a Neutral rating.
Wells Fargo Analyst forecast on XRAY
Vik ChopraWells Fargo
Wells Fargo
$19$16
Hold
-2.08%
Downside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Lowered to $16 at Wells FargoWells Fargo analyst Vik Chopra lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $16.00 (from $19.00) while maintaining a Equal Weight rating.
J.P. Morgan Analyst forecast on XRAY
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$20$17
Hold
4.04%
Upside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JPMorganJPMorgan analyst Tycho Peterson lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Neutral rating.
Morgan Stanley Analyst forecast on XRAY
Erin WrightMorgan Stanley
Morgan Stanley
$14
Hold
-14.32%
Downside
Reiterated
05/08/25
DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties
Bank of America Securities Analyst forecast on XRAY
Allen LutzBank of America Securities
Bank of America Securities
$16$17
Hold
4.04%
Upside
Reiterated
05/08/25
DENTSPLY SIRONA: Hold Rating Amid Stabilizing Growth and Macro Challenges
Leerink Partners Analyst forecast on XRAY
Michael ChernyLeerink Partners
Leerink Partners
$14.5
Hold
-11.26%
Downside
Reiterated
05/08/25
Cautious Optimism for DENTSPLY SIRONA Amid Market Challenges: Hold Rating Maintained
William Blair Analyst forecast on XRAY
Brandon VazquezWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Needham
Hold
Reiterated
05/08/25
DENTSPLY SIRONA: Hold Rating Amid Strong Performance and CFO Uncertainty
Evercore ISI
$15$17
Hold
4.04%
Upside
Reiterated
05/08/25
Cautious Optimism for DENTSPLY SIRONA Amid Recovery and Challenges: Hold Rating Maintained with Price Target at $17
Piper Sandler Analyst forecast on XRAY
Jason BednarPiper Sandler
Piper Sandler
$20$16
Hold
-2.08%
Downside
Reiterated
04/30/25
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY), Repligen (NASDAQ: RGEN) and Zynex (NASDAQ: ZYXI)
Jefferies
$20$17
Hold
4.04%
Upside
Reiterated
03/06/25
DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JefferiesJefferies analyst Brandon Couillard lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Hold rating.
Robert W. Baird Analyst forecast on XRAY
Jeff JohnsonRobert W. Baird
Robert W. Baird
$22$20
Hold
22.40%
Upside
Reiterated
02/28/25
Dentsply Sirona price target lowered to $20 from $22 at BairdDentsply Sirona price target lowered to $20 from $22 at Baird
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on XRAY
TipRanks AITipRanks
Not Ranked
TipRanks
$16
Hold
-2.08%
Downside
Reiterated
05/23/25
DENTSPLY SIRONA faces significant financial challenges, as evidenced by declining revenues and profitability, which heavily impact its overall score. Technical analysis provides some short-term optimism, but long-term resistance remains. Valuation is unattractive due to a negative P/E ratio, though the dividend yield is a partial offset. The earnings call highlights operational efficiency improvements, yet U.S. sales declines and tariff impacts are concerns. Corporate events indicate potential instability in leadership.
Barrington Analyst forecast on XRAY
Michael PetuskyBarrington
Barrington
$20$21
Buy
28.52%
Upside
Reiterated
05/12/25
Dentsply Sirona price target raised to $21 from $20 at BarringtonDentsply Sirona price target raised to $21 from $20 at Barrington
UBS
$27$25
Buy
53.00%
Upside
Reiterated
05/09/25
Dentsply Sirona price target lowered to $25 from $27 at UBSDentsply Sirona price target lowered to $25 from $27 at UBS
Mizuho Securities Analyst forecast on XRAY
Steven ValiquetteMizuho Securities
Mizuho Securities
$16$17
Hold
4.04%
Upside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Raised to $17 at MizuhoMizuho analyst Steven Valiquette raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $16.00) while maintaining a Neutral rating.
Wells Fargo Analyst forecast on XRAY
Vik ChopraWells Fargo
Wells Fargo
$19$16
Hold
-2.08%
Downside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Lowered to $16 at Wells FargoWells Fargo analyst Vik Chopra lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $16.00 (from $19.00) while maintaining a Equal Weight rating.
J.P. Morgan Analyst forecast on XRAY
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$20$17
Hold
4.04%
Upside
Reiterated
05/09/25
DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JPMorganJPMorgan analyst Tycho Peterson lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Neutral rating.
Morgan Stanley Analyst forecast on XRAY
Erin WrightMorgan Stanley
Morgan Stanley
$14
Hold
-14.32%
Downside
Reiterated
05/08/25
DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties
Bank of America Securities Analyst forecast on XRAY
Allen LutzBank of America Securities
Bank of America Securities
$16$17
Hold
4.04%
Upside
Reiterated
05/08/25
DENTSPLY SIRONA: Hold Rating Amid Stabilizing Growth and Macro Challenges
Leerink Partners Analyst forecast on XRAY
Michael ChernyLeerink Partners
Leerink Partners
$14.5
Hold
-11.26%
Downside
Reiterated
05/08/25
Cautious Optimism for DENTSPLY SIRONA Amid Market Challenges: Hold Rating Maintained
William Blair Analyst forecast on XRAY
Brandon VazquezWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Needham
Hold
Reiterated
05/08/25
DENTSPLY SIRONA: Hold Rating Amid Strong Performance and CFO Uncertainty
Evercore ISI
$15$17
Hold
4.04%
Upside
Reiterated
05/08/25
Cautious Optimism for DENTSPLY SIRONA Amid Recovery and Challenges: Hold Rating Maintained with Price Target at $17
Piper Sandler Analyst forecast on XRAY
Jason BednarPiper Sandler
Piper Sandler
$20$16
Hold
-2.08%
Downside
Reiterated
04/30/25
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY), Repligen (NASDAQ: RGEN) and Zynex (NASDAQ: ZYXI)
Jefferies
$20$17
Hold
4.04%
Upside
Reiterated
03/06/25
DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JefferiesJefferies analyst Brandon Couillard lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Hold rating.
Robert W. Baird Analyst forecast on XRAY
Jeff JohnsonRobert W. Baird
Robert W. Baird
$22$20
Hold
22.40%
Upside
Reiterated
02/28/25
Dentsply Sirona price target lowered to $20 from $22 at BairdDentsply Sirona price target lowered to $20 from $22 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

1 Month
xxx
Success Rate
14/35 ratings generated profit
40%
Average Return
-2.46%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -2.46% per trade.
3 Months
xxx
Success Rate
9/35 ratings generated profit
26%
Average Return
-5.39%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.71% of your transactions generating a profit, with an average return of -5.39% per trade.
1 Year
Michael PetuskyBarrington
Success Rate
4/35 ratings generated profit
11%
Average Return
-21.80%
reiterated a buy rating 17 days ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 11.43% of your transactions generating a profit, with an average return of -21.80% per trade.
2 Years
xxx
Success Rate
1/35 ratings generated profit
3%
Average Return
-31.82%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 2.86% of your transactions generating a profit, with an average return of -31.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XRAY Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
1
1
1
1
1
Buy
5
7
6
5
2
Hold
14
19
19
19
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
27
26
25
20
In the current month, XRAY has received 3 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. XRAY average Analyst price target in the past 3 months is 17.41.
Each month's total comprises the sum of three months' worth of ratings.

XRAY Financial Forecast

XRAY Earnings Forecast

Next quarter’s earnings estimate for XRAY is $0.50 with a range of $0.46 to $0.55. The previous quarter’s EPS was $0.43. XRAY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.
Next quarter’s earnings estimate for XRAY is $0.50 with a range of $0.46 to $0.55. The previous quarter’s EPS was $0.43. XRAY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Sales Forecast

Next quarter’s sales forecast for XRAY is $930.50M with a range of $911.20M to $952.00M. The previous quarter’s sales results were $879.00M. XRAY beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.58% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.
Next quarter’s sales forecast for XRAY is $930.50M with a range of $911.20M to $952.00M. The previous quarter’s sales results were $879.00M. XRAY beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.58% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Stock Forecast FAQ

What is XRAY’s average 12-month price target, according to analysts?
Based on analyst ratings, DENTSPLY SIRONA Inc’s 12-month average price target is 17.41.
    What is XRAY’s upside potential, based on the analysts’ average price target?
    DENTSPLY SIRONA Inc has 6.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is XRAY a Buy, Sell or Hold?
          DENTSPLY SIRONA Inc has a consensus rating of Hold which is based on 3 buy ratings, 10 hold ratings and 0 sell ratings.
            What is DENTSPLY SIRONA Inc’s price target?
            The average price target for DENTSPLY SIRONA Inc is 17.41. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $25.00 ,the lowest forecast is $14.00. The average price target represents 6.55% Increase from the current price of $16.34.
              What do analysts say about DENTSPLY SIRONA Inc?
              DENTSPLY SIRONA Inc’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of XRAY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis